Literature DB >> 19327525

Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure.

Daniel Zimpfer1, Seyedhossein Aharinejad, Johannes Holfeld, Anita Thomas, Julia Dumfarth, Raphael Rosenhek, Martin Czerny, Wolfgang Schaden, Mathias Gmeiner, Ernst Wolner, Michael Grimm.   

Abstract

OBJECTIVES: Direct application of low-energy unfocused shock waves induces angiogenesis in ischemic soft tissue. The potential effects of epicardial shock wave therapy applied in direct contact to ischemic myocardium are uncertain.
METHODS: For induction of ischemic heart failure in a rodent model, a left anterior descending artery ligation was performed in adult Sprague-Dawley rats. After 4 weeks, reoperation with (treatment group, n = 60) or without (control group, n = 60) epicardial shock wave therapy was performed. Low-energy shock waves were applied in direct contact with the infarcted myocardium (300 impulses at 0.38 mJ/m(2)). Additionally, healthy animals (n = 30) with normal myocardium were studied. Angiogenesis, ventricular function upregulation of growth factors, and brain natriuretic peptide levels were analyzed.
RESULTS: Histologic analysis revealed significant angiogenesis 6 weeks (treatment group: 8.2 +/- 3.7 vs control group: 2.9 +/- 1.9 vessels per field, P = .016) and 14 weeks (treatment group: 7.1 +/- 3.1 vs control group: 3.2 +/- 1.8 vessels per field, P = .011) after shock wave treatment. In the treatment group ventricular function improved throughout the follow-up period (6 weeks: 37.4% +/- 9% [P < .001] and 14 weeks: 39.5% +/- 9% [P < .001]). No improvement of ventricular function was observed in the control group (6 weeks: 28.6% +/- 5% and 14 weeks: 21.4% +/- 5%). Rat brain natriuretic peptide 45 levels were lower in the treatment group compared with those in the control group 6 and 14 weeks after treatment. Vascular endothelial growth factor, Fms-related tyrosine kinase 1, and placental growth factor levels were upregulated after 24 and 48 hours and 7 days in the treatment group. No effects on healthy myocardium were observed.
CONCLUSION: Direct epicardial low-energy shock wave therapy induces angiogenesis and improves ventricular function in a rodent model of ischemic heart failure.

Entities:  

Mesh:

Year:  2009        PMID: 19327525     DOI: 10.1016/j.jtcvs.2008.11.006

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  17 in total

1.  [Trigger points - Diagnosis and treatment concepts with special reference to extracorporeal shockwaves].

Authors:  M Gleitz; K Hornig
Journal:  Orthopade       Date:  2012-02       Impact factor: 1.087

2.  Study of vascular injuries using endothelial denudation model and the therapeutic application of shock wave: a review.

Authors:  Cheuk-Kwan Sun; Pei-Lin Shao; Ching-Jen Wang; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2011-04-08       Impact factor: 4.060

3.  [Basic research in traumatology and its contribution to routine operation].

Authors:  T Hausner; H Redl
Journal:  Unfallchirurg       Date:  2017-02       Impact factor: 1.000

4.  Regenerative concepts in cardiovascular research: novel hybrid therapy for remodeling ischemic cardiomyopathy.

Authors:  Prashant Rao; Rinku Skaria; Zain Khalpey
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

5.  Extracorporeal shockwave myocardial therapy is efficacious in improving symptoms in patients with refractory angina pectoris--a multicenter study.

Authors:  Megha Prasad; Wan Azman Wan Ahmad; Renan Sukmawan; Edward-Bengie L Magsombol; Andrew Cassar; Yuri Vinshtok; Muhammad Dzafir Ismail; Ahmad Syadi Mahmood Zuhdi; Sue Ann Locnen; Rodney Jimenez; Homobono Callleja; Amir Lerman
Journal:  Coron Artery Dis       Date:  2015-05       Impact factor: 1.439

6.  The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina.

Authors:  Gianluca Alunni; Sebastiano Marra; Ilaria Meynet; Maurizio D'amico; Pelloni Elisa; Annalaura Fanelli; Stefano Molinaro; Paolo Garrone; Armando Deberardinis; Mario Campana; Amir Lerman
Journal:  Cardiovasc Revasc Med       Date:  2014-11-10

7.  Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model.

Authors:  Xuefeng Qiu; Guiting Lin; Zhongcheng Xin; Ludovic Ferretti; Haiyang Zhang; Tom F Lue; Ching-Shwun Lin
Journal:  J Sex Med       Date:  2012-12-17       Impact factor: 3.802

8.  Shockwave therapy differentially stimulates endothelial cells: implications on the control of inflammation via toll-Like receptor 3.

Authors:  Johannes Holfeld; Can Tepeköylü; Radoslaw Kozaryn; Anja Urbschat; Kai Zacharowski; Michael Grimm; Patrick Paulus
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

9.  Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment.

Authors:  Morgan Fu; Cheuk-Kwan Sun; Yu-Chun Lin; Ching-Jen Wang; Chiung-Jen Wu; Sheung-Fat Ko; Sarah Chua; Jiunn-Jye Sheu; Chiang-Hua Chiang; Pei-Lin Shao; Steve Leu; Hon-Kan Yip
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

10.  Cardiac shock wave therapy: assessment of safety and new insights into mechanisms of tissue regeneration.

Authors:  Franca Di Meglio; Daria Nurzynska; Clotilde Castaldo; Rita Miraglia; Veronica Romano; Antonella De Angelis; Elena Piegari; Sergio Russo; Stefania Montagnani
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.